| Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas M Kool, A Korshunov, M Remke, DTW Jones, M Schlanstein, PA Northcott, ... Acta neuropathologica 123, 473-484, 2012 | 1152 | 2012 |
| Subgroup-specific structural variation across 1,000 medulloblastoma genomes PA Northcott, DJH Shih, J Peacock, L Garzia, A Sorana Morrissy, ... Nature 488 (7409), 49-56, 2012 | 983 | 2012 |
| Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials DS Hong, SG DuBois, S Kummar, AF Farago, CM Albert, KS Rohrberg, ... The Lancet Oncology 21 (4), 531-540, 2020 | 844 | 2020 |
| Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition M Kool, DTW Jones, N Jäger, PA Northcott, TJ Pugh, V Hovestadt, ... Cancer cell 25 (3), 393-405, 2014 | 826 | 2014 |
| Risk stratification of childhood medulloblastoma in the molecular era: the current consensus V Ramaswamy, M Remke, E Bouffet, S Bailey, SC Clifford, F Doz, M Kool, ... Acta neuropathologica 131, 821-831, 2016 | 634 | 2016 |
| Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial B Lannering, S Rutkowski, F Doz, B Pizer, G Gustafsson, A Navajas, ... Journal of clinical oncology 30 (26), 3187-3193, 2012 | 380 | 2012 |
| Retinoblastoma I Aerts, L Lumbroso-Le Rouic, M Gauthier-Villars, H Brisse, F Doz, ... Orphanet journal of rare diseases 1, 1-11, 2006 | 378 | 2006 |
| Cytogenetic prognostication within medulloblastoma subgroups DJH Shih, PA Northcott, M Remke, A Korshunov, V Ramaswamy, M Kool, ... Journal of clinical oncology 32 (9), 886-896, 2014 | 364 | 2014 |
| Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1) A retrospective study of 104 patients JS Guillamo, A Creange, C Kalifa, J Grill, D Rodriguez, F Doz, S Barbarot, ... Brain 126 (1), 152-160, 2002 | 337 | 2002 |
| A proposal for an international retinoblastoma staging system G Chantada, F Doz, CBG Antoneli, R Grundy, FF Clare Stannard, ... Pediatric blood & cancer 47 (6), 801-805, 2006 | 328 | 2006 |
| Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children J Grill, C Sainte-Rose, A Jouvet, JC Gentet, O Lejars, D Frappaz, F Doz, ... The lancet oncology 6 (8), 573-580, 2005 | 328 | 2005 |
| Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution F Khelfaoui, P Validire, A Auperin, E Quintana, J Michon, H Pacquement, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 1996 | 323 | 1996 |
| Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology J Grill, MC Le Deley, D Gambarelli, MA Raquin, D Couanet, ... Journal of Clinical Oncology 19 (5), 1288-1296, 2001 | 322 | 2001 |
| Beta‐catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics S Fattet, C Haberler, P Legoix, P Varlet, A Lellouch‐Tubiana, S Lair, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009 | 253 | 2009 |
| Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor F Bourdeaut, D Lequin, L Brugieres, S Reynaud, C Dufour, F Doz, ... Clinical Cancer Research 17 (1), 31-38, 2011 | 234 | 2011 |
| Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma S Postel-Vinay, AS Véron, F Tirode, G Pierron, S Reynaud, H Kovar, ... Nature genetics 44 (3), 323-327, 2012 | 207 | 2012 |
| Temozolomide in malignant gliomas of childhood: a United Kingdom children’s cancer study group and French society for pediatric oncology intergroup study LS Lashford, P Thiesse, A Jouvet, T Jaspan, D Couanet, PD Griffiths, ... Journal of Clinical Oncology 20 (24), 4684-4691, 2002 | 202 | 2002 |
| Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and … X Sastre, GL Chantada, F Doz, MW Wilson, MTG De Davila, ... Archives of pathology & laboratory medicine 133 (8), 1199-1202, 2009 | 200 | 2009 |
| Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy—results of the first French prospective … V Laithier, J Grill, MC Le Deley, MM Ruchoux, D Couanet, F Doz, ... Journal of clinical oncology 21 (24), 4572-4578, 2003 | 200 | 2003 |
| TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma M Remke, V Ramaswamy, J Peacock, DJH Shih, C Koelsche, ... Acta neuropathologica 126, 917-929, 2013 | 198 | 2013 |
